References
- Boison D, Stewart KA. Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation. Biochem Pharmacol. 2009;78:1428–37.
- Waldbaum S, Patel M. Mitochondrial dysfunction and oxidative stress: a contributing link to acquired epilepsy? J Bioenerg Biomembr. 2010;42(6):449–55.
- Barros DO, Xavier SM, Barbosa CO, Silva RF, Freitas RL, Maia FD, et al. Effects of the vitamin E in catalase activities in hippocampus after status epilepticus induced by pilocarpine in Wistar rats. Neurosci Lett. 2007;416:227–30.
- Deshpande LS, Sun DA, Sombati S, Baranova A, Wilson MS, Attkisson E, et al. Alterations in neuronal calcium levels are associated with cognitive deficits after traumatic brain injury. Neurosci Lett. 2008;441:115–9.
- Boison D. Cell and gene therapies for refractory epilepsy. Curr Neuropharmacol. 2007;5:115–25.
- Jacobson KA, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov. 2006;5:247–64.
- Boison D. Adenosine-based cell therapy approaches for pharmacoresistant epilepsies. Neurodegener Dis. 2007;4:28–33.
- Cunha RA. Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade. Purinergic Signal. 2005;1:111–34.
- León OS, Menéndez S, Merino N, Castillo R, Sam S, Pérez L, et al. Ozone oxidative preconditioning a protection against cellular damage by free radicals. Mediators Inflamm. 1998;7:289–94.
- Ajamieh HH, Merino N, Candelario-Jalil E, Menéndez S, Martínez-Sánchez G, Re L, et al. Similar protective effect of ischaemic and ozone oxidative preconditioning in liver ischaemia/reperfusion injury. Pharmacol Res. 2002;45:333–9.
- Ajamieh HH, Menéndez S, Martínez-Sánchez G, Candelario-Jalil E, Re L, Giuliani A, et al. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver Int. 2004;24:55–62.
- Ajamieh HH, Berlanga J, Merino N, Sánchez GM, Carmona AM, Cepero SM, et al. Role of protein synthesis in the protection conferred by ozone-oxidative-preconditioning in hepatic ischaemia/reperfusion. Transpl Int. 2005;18:604–12.
- León Fernández OS, Ajamieh HH, Berlanga J, Menéndez S, Viebahn-Hánsler R, Re L, et al. Ozone oxidative preconditioning is mediated by A1 adenosine receptors in a rat model of liver ischemia/reperfusion. Transpl Int. 2008;21:29–48.
- Al-Dalain SM, Martínez G, Candelario-Jalil E, Menéndez S, Re L, Giuliani A, et al. Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res. 2001;44:391–6.
- Martínez-Sánchez GM, Al-Dalain SM, Menéndez S, Re L, Giuliani A, Candelario-Jalil E, et al. Therapeutic efficacy of ozone in patients with diabetic foot. Eur J Pharmacol. 2005;523:151–61.
- León Fernández OS, Pantoja M, Díaz Soto MT, Dranguet J, García Insua M, Viebhan-Hánsler R, et al. Ozone oxidative post-conditioning reduces oxidative protein damage in patients with disc hernia. Neurol Res. 2012;34:59–67.
- Murry CE, Jennings RB, Reime KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–36.
- Shafaroodi H, Samini M, Moezi L, Homayoun H, Sadeghipour H, Tavakoli S, et al. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice. Neuropharmacology. 2004;47:390–400.
- Cheung CC, Yang C, Berger T, Zaugg K, Reilly P, Elia AJ, et al. Identification of BERP (brain-expressed RING fingerprotein) as a p53 target gene that modulates seizure susceptibility through interacting with GABAA receptors. Proc Natl Acad Sci U S A. 2010;107(26):11883–8.
- Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation product: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407–21.
- Witko-Sarsat V, Friedlander M, Nguyen-Khoa T, Capellére-Bladin C, Nguyen A, Canteloup S, et al. Advanced oxidation protein products as novel mediators of inflammation and monocytes activation in chronic renal failure. J Immunol. 1998;161:2524–32.
- Özdermirler G, Mehmetcik G, Öztezcan S. Peroxidation and antioxidant activity of serum in patients with diabetes mellitus and myocardial infarction. Horm Metab Res. 1995;27:194–6.
- Sedlak J, Lindsay RH. Estimation of total protein-bound and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 1968;25:192–205.
- Boehringer Mannheim. Biochemica information. A revised biochemical reference source. Enzymes for routine, 1st edn. Berlin: Boehringer Mannheim; 1987. p. 15–6.
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.
- Li T, Ren G, Lusardi T, Wilz A, Lan JQ, Iwasato T, et al. Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest. 2008;2:571–82.
- Etherington LA, Frenguelli BG. Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner. Eur J Neurosci. 2004;19:2539–50.
- Fedele DE, Li T, Lan JQ, Fredholm BB, Boison D. Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp Neurol. 2006;200:184–90.
- During MJ, Spencer DD. Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann Neurol. 1992;32:618–24.
- Dale N, Frenguelli BG. Release of adenosine and ATP during ischemia and epilepsy. Curr Neuropharmacol. 2009;7:160–79.
- Peralta C, Xaus C, Bartrons R, Leon OS, Gelpi E, Roselló-Catafau J. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia/reperfusion. Free Radic Res. 2000;33:595–605.